Cargando…

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer

The survival risk following curative surgery for nonmetastatic colorectal cancer (CRC) may be over‐ or underestimated due to a lack of attention to nonlinear effects and violation of the proportional hazards assumption. In this paper, we aimed to detect and interpret the shape of time‐dependent and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Sheng‐Qiang, Tian, Yu, Li, Jun, Tong, Dan‐yang, Kong, Xiang‐Xing, Poston, Graeme, Ding, Ke‐Feng, Li, Jing‐Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548888/ https://www.ncbi.nlm.nih.gov/pubmed/28707427 http://dx.doi.org/10.1002/cam4.1116

Ejemplares similares

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2019)

Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer
por: Tian, Yu, et al.
Publicado: (2018)

National Cancer Database report of nonmetastatic esophageal small cell carcinoma
por: Verma, Vivek, et al.
Publicado: (2018)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population‐based study
por: Xiao, Yu, et al.
Publicado: (2020)

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
por: Abdel-Rahman, Omar, et al.
Publicado: (2018)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer
por: Gruhl, Joshua D., et al.
Publicado: (2020)

Liquid biopsy by NGS: differential presence of exons (DPE) in cell‐free DNA reveals different patterns in metastatic and nonmetastatic colorectal cancer
por: Olmedillas‐López, Susana, et al.
Publicado: (2018)

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
por: Fountzilas, Elena, et al.
Publicado: (2019)

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Li, Fazhan, et al.
Publicado: (2021)

Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma
por: Kobayashi, Kenya, et al.
Publicado: (2016)

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2022)

Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer
por: Kanematsu, Masako, et al.
Publicado: (2015)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer
por: Rodriguez, Nicole, et al.
Publicado: (2021)

Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer
por: Sun, Yu, et al.
Publicado: (2020)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population‐based study
por: van der Geest, Lydia G. M., et al.
Publicado: (2018)

Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort
por: Fadelu, Temidayo, et al.
Publicado: (2020)

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
por: Suzuki, Hiroyoshi, et al.
Publicado: (2019)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
por: Miranda, E, et al.
Publicado: (2006)

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer
por: Hong, Ting-Ting, et al.
Publicado: (2016)

A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database
por: Kong, Xiangxing, et al.
Publicado: (2018)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy
por: O'Neil, Daniel S., et al.
Publicado: (2018)

Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancer
por: Forster, Rachel B., et al.
Publicado: (2022)

Prognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for nonmetastatic rectal cancer
por: Wu, Qing-Bin, et al.
Publicado: (2016)

The prognostic value of clinical and pathologic features in nonmetastatic operable male breast cancer
por: Sun, Bo, et al.
Publicado: (2016)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Expression of immune checkpoint receptors Indoleamine 2,3‐dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
por: Stålhammar, Gustav, et al.
Publicado: (2019)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer
por: Wang, Guosen, et al.
Publicado: (2020)

Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism
por: Wang, Qi, et al.
Publicado: (2021)

Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway
por: Wang, Wei, et al.
Publicado: (2019)

Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis
por: Bamias, Aristotle, et al.
Publicado: (2016)

Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
por: Wang, Yuwei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jtr70iduqbv5smd6gqo5rpd9hs